Table 3.
Chemotherapy dose modifications and delays
| Cycles (n = 256) | Patients (n = 50) | |||
|---|---|---|---|---|
| Methotrexate dose modification | 35 | 13.7% | 14 | 28% |
| BCNU dose modification | 38 | 14.8% | 14 | 28% |
| Any dose modification | 55 | 21.5% | 18 | 36% |
| Cycle delay | 22 | 8.6% | 10 | 20% |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.